Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance

<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br>...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Wiley 2021

समान संसाधन

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
द्वारा: Xu, S, और अन्य
प्रकाशित: (2019)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
द्वारा: Wamil, M, और अन्य
प्रकाशित: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
द्वारा: Leal, J, और अन्य
प्रकाशित: (2022)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
द्वारा: Califf, R, और अन्य
प्रकाशित: (2003)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
द्वारा: Currie, G, और अन्य
प्रकाशित: (2017)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
द्वारा: Liam Mc Morrow, और अन्य
प्रकाशित: (2024-02-01)

Impaired glucose tolerance: who and how treats it?
द्वारा: M. N. Mamedov
प्रकाशित: (2005-12-01)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
द्वारा: Holman, R, और अन्य
प्रकाशित: (2017)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
द्वारा: Yates, T, और अन्य
प्रकाशित: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
द्वारा: Yates, T, और अन्य
प्रकाशित: (2014)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
द्वारा: Wamil, M, और अन्य
प्रकाशित: (2021)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
द्वारा: Susanne Andersson, और अन्य
प्रकाशित: (2011-01-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
द्वारा: Nihar Ranjan Mohanty, और अन्य
प्रकाशित: (2022-06-01)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
द्वारा: Wamil, M, और अन्य
प्रकाशित: (2020)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
द्वारा: Farrer, M, और अन्य
प्रकाशित: (1993)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
द्वारा: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
प्रकाशित: (2012-01-01)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
द्वारा: Preiss, D, और अन्य
प्रकाशित: (2013)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
द्वारा: Califf, R, और अन्य
प्रकाशित: (2008)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
द्वारा: Holman, R
प्रकाशित: (1996)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
द्वारा: Yutaka Inoue, और अन्य
प्रकाशित: (2022-06-01)

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance.
द्वारा: Page, R, और अन्य
प्रकाशित: (1993)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
द्वारा: Ursula Mager, और अन्य
प्रकाशित: (2008-08-01)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
द्वारा: Xin Zhang, और अन्य
प्रकाशित: (2023-01-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
द्वारा: Anke Tönjes, और अन्य
प्रकाशित: (2010-01-01)

Associations of green tea and rock tea consumption with risk of impaired fasting glucose and impaired glucose tolerance in Chinese men and women.
द्वारा: Huibin Huang, और अन्य
प्रकाशित: (2013-01-01)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
द्वारा: Gerstein, H, और अन्य
प्रकाशित: (2006)

Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial
द्वारा: Preiss, D, और अन्य
प्रकाशित: (2012)

Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis
द्वारा: Zhen Yang, और अन्य
प्रकाशित: (2017-09-01)

International variation in outcomes among people with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the NAVIGATOR Trial.
द्वारा: Dos Santos, M, और अन्य
प्रकाशित: (2017)

Impaired glucose tolerance in sleep disorders.
द्वारा: Marietta Keckeis, और अन्य
प्रकाशित: (2010-03-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
द्वारा: Stevens, R, और अन्य
प्रकाशित: (2005)

Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease
द्वारा: Brkić Milena, और अन्य
प्रकाशित: (2022-01-01)

Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes
द्वारा: Yupu Liu, और अन्य
प्रकाशित: (2022-02-01)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
द्वारा: Mostafa, SA, और अन्य
प्रकाशित: (2017)

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
द्वारा: Mc Morrow, L, और अन्य
प्रकाशित: (2018)

Impaired Sensitivity to Thyroid Hormones Is Associated With Elevated Blood Glucose in Coronary Heart Disease
द्वारा: Lu Yu, और अन्य
प्रकाशित: (2022-06-01)

International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial
द्वारा: Marilia Harumi Higuchi dos Santos, और अन्य
प्रकाशित: (2017-01-01)

List of people who have paid
द्वारा: Cork County Association, CCA

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
द्वारा: Latini, R, और अन्य
प्रकाशित: (2013)

Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.
द्वारा: Sharma, A, और अन्य
प्रकाशित: (2016)